ALKERMES, INC.

Lobbying client · Massachusetts · filed 2026 to 2026

biopharmaceutical company

$110,000 Reported spend

3 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (192194), not by name.

Firms hired 1

CROSSROADS STRATEGIES, LLC $110,000 3 filings

Reported by year 1 year

2026 $110,000 3 filings

Issues lobbied 1

Pharmacy 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 3 total

Q2

CROSSROADS STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 18, 2026

View → Q1

CROSSROADS STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000 income · posted Apr 19, 2026

View → RA

CROSSROADS STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · posted Feb 13, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.